Silvaco Group, Inc.
For the period ended Jun 30, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2026 · Filed Aug 6, 2026
SVCO$7.03+4.5%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in thousands)
| Six Months Ended June 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities: | ||
| Net loss | $(9,537) | $(28,682) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Depreciation and amortization | 2,475 | 1,146 |
| Stock-based compensation expense | 5,831 | 4,397 |
| Provision for estimated credit losses | 154 | 116 |
| Litigation settlement | — | 13,069 |
| Accretion (amortization) of discounts (premiums) on marketable securities, net | 18 | (462) |
| Change in fair value of contingent consideration | 187 | 52 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (1,895) | 97 |
| Contract assets | (449) | 4,832 |
| Prepaid expenses and other current assets | (314) | (1,073) |
| Other assets | 204 | 32 |
| Accounts payable | (896) | (1,576) |
| Accrued expenses and other current liabilities | (6,780) | (16,586) |
| Related party funding of litigation settlement | — | 6,000 |
| Accrued income taxes | (1,492) | (714) |
| Deferred revenue | (2,917) | 2,719 |
| Other non-current liabilities | (1,113) | 20 |
| Net cash used in operating activities | (16,524) | (16,613) |
| Cash flows from investing activities: | ||
| Sales of marketable securities | — | 10,345 |
| Maturities of marketable securities | 1,000 | 32,000 |
| Acquisition of businesses | — | (14,306) |
| Purchases of property and equipment | (14) | (222) |
| Net cash provided by investing activities | 986 | 27,817 |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock | 12,193 | 361 |
| Payments of equity issuance costs | (606) | — |
| Payment of payroll taxes related to shares withheld from employees | (287) | (586) |
| Payments of contingent consideration | (43) | (46) |
| Payments of vendor financing obligation | — | (1,328) |
| Net cash provided by (used in) financing activities | 11,257 | (1,599) |
| Effect of exchange rate fluctuations on cash and cash equivalents | 23 | 421 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (4,258) | 10,026 |
| Cash, cash equivalents, and restricted cash beginning of period | 17,258 | 19,606 |
| Cash, cash equivalents, and restricted cash, end of period | $13,000 | $29,632 |
| Cash and cash equivalents | 13,000 | 13,132 |
| Restricted cash | — | 16,500 |
| Total cash, cash equivalents and restricted cash | $13,000 | $29,632 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.